Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**DL-lactic acid** is the racemic mixture (1:1 ratio) of D-lactic acid and L-lactic acid enantiomers, with the molecular formula C3H6O3. It is a colorless to yellow, syrupy, water-soluble organic acid, classified as an alpha-hydroxy acid (AHA). DL-lactic acid serves as a chemical intermediate, acidulant, and keratolytic agent. Its main uses include: - **Pharmaceuticals and Cosmetics:** Acts as a pH regulator, keratolytic, and humectant, and is used for manufacturing water-soluble lactate salts, topical preparations, and cleansing/antibacterial agents. - **Food Industry:** Employed as an acidulant and preservative. - **Industrial Uses:** Precursor for polylactic acid (PLA) production (biodegradable plastics), mordant in textiles, and incorporated in various products such as food, beverages, leather, and plastics. The mechanism of action in medicinal and cosmetic applications involves keratolysis (promoting exfoliation of the stratum corneum) and acidification, producing antibacterial effects and contributing to humectant properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dl-lactic acid.